Artificial Intelligence in Pharmaceuticals: Revolutionizing Healthcare
Artificial intelligence accelerates drug discovery, optimizes clinical trials, and personalizes treatments, changing pharmaceutical innovation and healthcare delivery. See latest price on Amazon.
Quick facts
Topic: Healthcare
Tags: Healthcare, Artificial Intelligence, AI Trends
Length: 328 pages
Best for: Readers who want practical, plain-English AI insights with real-world examples.
Because AI in healthcare affects patient outcomes, safety, workload, and access to care. Getting the basics right matters long before anyone wheels in the hype machine.
What you’ll learn
Where AI is already being used in healthcare today — and where the claims are running ahead of reality.
The workflows, systems, and trade-offs behind practical healthcare use cases, explained in plain English.
Key themes including diagnosis, monitoring, decision support, workflow.
The limits, risks, and awkward questions worth asking before you sign off on the sales pitch.
Who this book is for
Healthcare professionals, managers, and policymakers who want to understand AI's practical role in diagnosis, treatment, and patient care.
What this book covers
Artificial intelligence accelerates drug discovery, optimizes clinical trials, and personalizes treatments.
What makes this book distinct
Drug discovery is being restructured by AI faster than most people realise. This book covers how ML models are compressing the early discovery phase from years to months, what that means for the economics of pharmaceutical development, and why the approval and clinical trial process remains the bottleneck that AI can't yet speed up.
Not your book? This is not a clinical or research guide — it's strategic and accessible. Pharmacists, researchers, and clinicians will find it useful as context, but it's primarily written for senior decision-makers and informed general readers.
Jonathan HarrisArtificial Intelligence Author & Host of Turing's Torch AI Weekly
Longer-form context from the retired overview page, now folded into the canonical book route.
Problem framing: where this topic gets messy
In healthcare, the awkward question is never whether AI can produce output. It is whether the output is clinically useful, auditable, and safe enough to influence treatment or diagnosis. Artificial intelligence accelerates drug discovery, optimizes clinical trials, and personalizes treatments. Pages: 328. Because AI in healthcare affects patient outcomes, safety, workload, and access to care. Getting the basics right matters long before anyone wheels in the hype machine.
Practical outcomes
In practical terms, the aim is simple: you should come away better able to separate serious clinical use-cases from vague promises dressed up as innovation. That means clearer judgement, fewer lazy assumptions, and a much better sense of where to press further or walk away.
Identify where ai is already being used in healthcare today — and where the claims are running ahead of reality.
Work through the workflows, systems, and trade-offs behind practical healthcare use cases, explained in plain english.
Work through key themes including diagnosis, monitoring, decision support, workflow.
Work through the limits, risks, and awkward questions worth asking before you sign off on the sales pitch.
Chapter-level signals
Not a chapter list carved in stone, but the sort of material readers can reasonably expect to work through.
Where AI is already being used
Where AI is already being used in healthcare today — and where the claims are running ahead of reality.
The workflows, systems, and trade-offs behind
The workflows, systems, and trade-offs behind practical healthcare use cases, explained in plain English.
Key themes including diagnosis, monitoring, decision
Key themes including diagnosis, monitoring, decision support, workflow.
The limits, risks, and awkward questions
The limits, risks, and awkward questions worth asking before you sign off on the sales pitch.
What makes this title distinct
Drug discovery is being restructured by AI faster than most people realise. This book covers how ML models are compressing the early discovery phase from years to months, what that means for the economics of pharmaceutical development, and why the approval and clinical trial process remains the bottleneck that AI can't yet speed up. Not your book? This is not a clinical or research guide — it's strategic and accessible. Pharmacists, researchers, and clinicians will find it useful as context, but it's primarily written for senior decision-makers and informed general readers.
